Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 910

Publication Record

Connections

Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors.
Wu MD, Moslehi JJ, Lindner JR
(2021) Arterioscler Thromb Vasc Biol 41: 3-10
MeSH Terms: Animals, Antineoplastic Agents, Arterial Occlusive Diseases, Humans, Molecular Targeted Therapy, Neoplasms, Protein Kinase Inhibitors, Protein-Tyrosine Kinases, Risk Assessment, Risk Factors, Thrombosis
Added January 23, 2021
0 Communities
1 Members
0 Resources
11 MeSH Terms
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R, Mueller C, Čelutkienė J, Henriksen PA, Lenihan D, Dent S, Barac A, Stanway S, Moslehi J, Suter TM, Ky B, Štěrba M, Cardinale D, Cohen-Solal A, Tocchetti CG, Farmakis D, Bergler-Klein J, Anker MS, Von Haehling S, Belenkov Y, Iakobishvili Z, Maack C, Ciardiello F, Ruschitzka F, Coats AJS, Seferovic P, Lainscak M, Piepoli MF, Chioncel O, Bax J, Hulot JS, Skouri H, Hägler-Laube ES, Asteggiano R, Fernandez TL, de Boer RA, Lyon AR
(2020) Eur J Heart Fail 22: 1966-1983
MeSH Terms: Antineoplastic Agents, Biomarkers, Tumor, Cardiotonic Agents, Cardiotoxicity, Heart Failure, Humans, Neoplasms
Added January 23, 2021
0 Communities
1 Members
0 Resources
7 MeSH Terms
Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity.
Miller JM, Meki MH, Ou Q, George SA, Gams A, Abouleisa RRE, Tang XL, Ahern BM, Giridharan GA, El-Baz A, Hill BG, Satin J, Conklin DJ, Moslehi J, Bolli R, Ribeiro AJS, Efimov IR, Mohamed TMA
(2020) Toxicol Appl Pharmacol 406: 115213
MeSH Terms: Adult, Aged, Animals, Antineoplastic Agents, Apoptosis, Cardiotoxicity, Cardiotoxins, Doxorubicin, Female, Heart, Humans, Induced Pluripotent Stem Cells, Male, Middle Aged, Models, Biological, Swine, Tissue Culture Techniques, Trastuzumab
Added September 29, 2020
0 Communities
1 Members
0 Resources
18 MeSH Terms
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance.
Geraud A, Gougis P, Vozy A, Anquetil C, Allenbach Y, Romano E, Funck-Brentano E, Moslehi JJ, Johnson DB, Salem JE
(2021) Annu Rev Pharmacol Toxicol 61: 85-112
MeSH Terms: Antineoplastic Agents, Immunological, Autoimmune Diseases, Humans, Immunotherapy, Neoplasms, Yin-Yang
Added September 29, 2020
0 Communities
1 Members
0 Resources
6 MeSH Terms
Casein Kinase 1α as a Regulator of Wnt-Driven Cancer.
Shen C, Nayak A, Melendez RA, Wynn DT, Jackson J, Lee E, Ahmed Y, Robbins DJ
(2020) Int J Mol Sci 21:
MeSH Terms: Animals, Antineoplastic Agents, Casein Kinase Ialpha, Enzyme Activators, Humans, Neoplasms, Wnt Signaling Pathway
Added August 24, 2020
0 Communities
1 Members
0 Resources
7 MeSH Terms
The cancer patient and cardiology.
Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G
(2020) Eur J Heart Fail 22: 2290-2309
MeSH Terms: Aftercare, Antineoplastic Agents, Cardiotoxicity, Humans, Neoplasms, Radiotherapy, Risk Assessment, Risk Factors
Added September 29, 2020
0 Communities
1 Members
0 Resources
8 MeSH Terms
Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity.
Wang S, Raybuck A, Shiuan E, Cho SH, Wang Q, Brantley-Sieders DM, Edwards D, Allaman MM, Nathan J, Wilson KT, DeNardo D, Zhang S, Cook R, Boothby M, Chen J
(2020) JCI Insight 5:
MeSH Terms: Animals, Antineoplastic Agents, Breast Neoplasms, Carcinoma, Lewis Lung, Disease Models, Animal, Endothelium, Vascular, Everolimus, Female, Humans, Lymphocytes, Tumor-Infiltrating, Mechanistic Target of Rapamycin Complex 1, Mice, Mice, Inbred C57BL, Signal Transduction
Added September 17, 2020
0 Communities
1 Members
0 Resources
14 MeSH Terms
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
Johnson DB, Reynolds KL, Sullivan RJ, Balko JM, Patrinely JR, Cappelli LC, Naidoo J, Moslehi JJ
(2020) Lancet Oncol 21: e398-e404
MeSH Terms: Antineoplastic Agents, Immunological, Humans, Medical Oncology, Neoplasms, Patient Care, Patient Education as Topic
Added September 29, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand.
Patrinely JR, Young AC, Quach H, Williams GR, Ye F, Fan R, Horn L, Beckermann KE, Gillaspie EA, Sosman JA, Friedman DL, Moslehi JJ, Johnson DB
(2020) Eur J Cancer 135: 211-220
MeSH Terms: Aged, Antineoplastic Agents, Immunological, B7-H1 Antigen, Body Composition, Female, Functional Status, Humans, Immune Checkpoint Inhibitors, Male, Middle Aged, Neoplasms, Nutritional Status, Programmed Cell Death 1 Receptor, Progression-Free Survival, Quality of Life, Retrospective Studies, Survivors, Time Factors
Added September 29, 2020
0 Communities
1 Members
0 Resources
18 MeSH Terms
Vascular medicine and cardio-oncology - A new, evolving clinical frontier.
Versmissen J, Power JR, Moslehi J
(2020) Vasc Med 25: 205-207
MeSH Terms: Antineoplastic Agents, Cancer Survivors, Cardiology, Heart Diseases, Humans, Medical Oncology, Neoplasms, Prognosis, Risk Assessment, Risk Factors, Specialization
Added September 29, 2020
0 Communities
1 Members
0 Resources
MeSH Terms